Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Fuchs Claudia |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Fuchs, C; Petrenko, O; Mlitz, V; Scharnagl, H; Stojakovic, T; Reiberger, T; Garfinkel, B; Trauner, M
Inhibition of bile acid conjugation improves DDC-induced cholestatic liver injury in mice with a humanized bile acid pool
J HEPATOL. Abstracts. 2024; 80: S296-S296.-EASL Congress; JUN 5-8, 2024; Milan, ITALY.
[Poster]
Web of Science
Dixon, ED; Nardo, AD; Claudel, T; Fuchs, C; Mlitz, V; Stojakovic, T; Scharnagl, H; Grabner, G; Zimmermann, R; Trauner, M
Chemical suppression of adipose triglyceride lipase improves non-alcoholic steatohepatitis in a diabetic and hyperlipidemic mouse model
J HEPATOL. 2022; 77: S688-S689.
[Poster]
Web of Science
Fuchs, C; Dixon, ED; Konigshofer, P; Mlitz, V; Scharnagl, H; Stojakovic, T; Reiberger, T; Trauner, M
Loss of bile salt export pump (BSEP/ABCB11) protects mice from development of carbon tetrachloride (CCl4) induced hepatic fibrosis
J HEPATOL. 2022; 77: S469-S469.
[Poster]
Web of Science
Menz, M; Hinterleitner, L; Konigshofer, P; Halilbasic, E; Kunczer, V; Stojakovic, T; Reiberger, T; Fuchs, C; Trauner, M
Glucagon like peptide-2 treatment improves liver and bile duct injury in the Mdr2-/- mouse model of sclerosing cholangitis
J HEPATOL. 2019; 70: E167-E168.
Doi: 10.1016/S0618-8278(19)30301-9
[Poster]
Web of Science
FullText
FullText_MUG
Remetic, J; Mlitz, V; Kunczer, V; Schargl, H; Stojakovic, T; Fuchs, C; Trauner, M
Loss of bile salt export pump (Bsep/Abcb11) aggravates lipopolysaccharide induced hepatic inflammation in mice
J HEPATOL. 2019; 70: E169-E169.
Doi: 10.1016/S0618-8278(19)30305-6
[Poster]
Web of Science
FullText
FullText_MUG
Zhu, C; Boucheron, N; Muller, A; Majek, P; Fuchs, C; Baazim, H; Lercher, A; Halilbasic, E; Gulich, A; Sakaguchi, S; Sandner, L; Stojakovic, T; Scharnagl, H; Bergthaler, A; Ellmeier, W; Trauner, M
24-nor-ursodeoxycholic acid ameliorates inflammation by reshaping mTOR proteome and immunometabolism sensing programs in CD8 T cells
EUR J IMMUNOL. 2019; 49: 1282-1282.-17th International Congress of Immunology (IUIS); OCT 19-23, 2019; Beijing, PEOPLES R CHINA.
[Poster]
Web of Science
Fuchs, C; Paumgartner, G; Mlitz, V; Wolfrum, S; Wahlstrom, A; Stahlman, M; Stojakovic, T; Wolfrum, C; Marschall, HU; Trauner, M
Loss of BSEP protects MDR2/ABCB4 KO mice from cholestatic liver injury by altering bile acid profile and signaling
J HEPATOL. 2018; 68: S449-S450.
Doi: 10.1016/S0168-8278(18)31141-3
Web of Science
FullText
FullText_MUG
Lemberger, U; Fuchs, C; Karer, M; Stojakovic, T; Meier, S; Schofer, C; Egger, G; Wrba, F; Gerner, C; Taketo, M; Trauner, M; Oesterreicher, CH;
HEPATOCYTE SPECIFIC EXPRESSION OF A DOMINANT STABLE FORM OF B-CATENIN RESULTS IN EARLY LETHALITY DUE TO DISTURBANCES IN LIPID AND GLUCOSE METABOLISM.
J HEPATOL. JOURNAL OF HEPATOLOGY64: S687-S687. AMSTERDAM: ELSEVIER SCIENCE BV; ( Presented at: EASL International Liver Congress, Barcelona, SPAIN, APR 13-17, 2016)
Doi: 10.1016/S0168-8278(16)01309-X
Web of Science
FullText
FullText_MUG
Fuchs, CD; Claudel, T; Halilbasic, E; Jha, P; Spindelboeck, W; Stojakovic, T; Trauner, M
ROLE OF FXR CONTROLLED Chop IN MEDIATING BILE ACID EFFECTS IN NAFLD.
J HEPATOL. 2015; 62(S2):S689-S689.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA.
[Poster]
Web of Science
Fuchs, CD; Paumgartner, G; Wahlström, A; Chiba, P; Stojakovic, T; Claudel, T; Marschall, HU; Trauner, M
ABSENCE OF BSEP/ABCB11 PROTECTS FROM CHOLESTATIC LIVER AND BILE DUCT INJURY IN A MOUSE MODEL OF SCLEROSING CHOLANGITIS.
J HEPATOL. 2015; 62(S2):S232-S232.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA.
[Oral Communication]
Fuchs, CD; Paumgartner, G; Wahlström, A; Stojakovic, T; Marschall, H; Trauner, M
Absence of BSEP/ABCB11 protects from cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
Z Gastroenterol. 2015; 53(5):512-512.-48. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 18-20, 2015; Salzburg, AUSTRIA.
[Poster]
Kienbacher, C; Traussnigg, S; Halilbasic, E; Fuchs, C; Dolak, W; Steindl-Munda, P; Stojakovic, T; Fauler, G; Claudel, T; Trauner, M
Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: potential role of bile acids?
Z Gastroenterol. 2015; 53(5):501-501.-48. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 18-20, 2015; Salzburg, AUSTRIA.
[Poster]
Lemberger, UJ; Fuchs, C; Karer, M; Schöfer, C; Stojakovic, T; Wrba, F; Taketo, MM; Trauner, M; Österreicher, CH
HEPATOCYTE SPECIFIC EXPRESSION OF A DOMINANT STABLE FORM OF BETA-CATENIN RESULTS IN CHOLESTATIC LIVER DISEASE.
J HEPATOL. 2015; 62(S2):S781-S781.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(15)31341-6
[Poster]
Web of Science
FullText
FullText_MUG
Fuchs, CD; Claudel, T; Halilbasic, E; Jha, P; Spindelboeck, W; Stojakovic, T; Trauner, M
Role of FXR controlled CHOP in mediating bile acid effects in NAFLD.
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY.
[Poster]
Fuchs, CD; Claudel, T; Halilbasic, E; Jha, P; Spindelboeck, W; Stojakovic, T; Trauner, M
FXR CONTROLLED CHOP AS NOVEL KEY PLAYER IN NAFLD PROGRESSION.
J HEPATOL. 2014; 60(S1):S148-S148.-49th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 9-13, 2014; London, UNITED KINGDOM.
[Poster]
Fuchs, CD; Claudel, T; Halilbasic, E; Stojakovic, T; Scharnagl, H; Österreicher, C; Hoesel, B; Paumgartner, G; Marschall, HU; Trauner, M
ABCB11 (BSEP) knockout mice are proteced from methionine choline deficient diet induced steatohepatitis.
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY.
[Poster]
Fuchs, CD; Paumgartner, G; Wahlstrom, A; Chiba, P; Stojakovic, T; Claudel, T; Marschall, HU; Trauner, M
Absence of BSEP/ABCB11 protects from cholestatic liver injury in mice.
HEPATOLOGY. 2014; 60: 405A-406A.-65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 07-11, 2014; Boston, USA.
[Poster]
Web of Science
Fuchs, CD; Paumgartner, G; Wahlström, A; Chiba, P; Stojakovic, T; Claudel, T; Marschall, HU; Trauner, M
Absence of BSEP/ABCB11 protects from cholestatic liver injury in mice.
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY.
[Poster]
Kienbacher, C; Traussnigg, S; Halilbasic, E; C; Fuchs, CD; Dolak, W; Steindl-Munda, P; Stojakovic, T; Fauler, G; Claudel, T; Trauner, M
DISTURBED ENERGY METABOLISM AND LIPID PROFILE AFTER A 4 WEEK HIGH ORAL FRUCTOSE CHALLENGE: POSSIBLE ROLE OF BILE ACIDS.
J HEPATOL. 2014; 60(S1):S351-S351.-49th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 9-13, 2014; London, UNITED KINGDOM.
[Poster]
Kienbacher, C; Traussnigg, S; Halilbasic, E; Fuchs, C; Dolak, W; Steindl-Munda, P; Stojakovic, T; Fauler, G; Gajdosik, M; Krebs, M; Claudel, T; Trattnig, S; Krssak, M; Trauner, M
Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: Potential role of bile acids?
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY.
[Poster]
Bettermann, K; Mehta, AK; Lederer, E; Ernst, C; Kessler, SM; Chen, X; Hoshida, Y; Bardeesy, N; Fuchs, BC; Tanabe, KK; Müller, H; Svendova, V; Schimek, MG; Mach, M; Speicher, MR; Mahajan, V; Stumptner, C; Thueringer, A; Stojakovic, T; Longerich, T; Schirmacher, P; Magin, TM; Strnad, P; Fuchs, CD; Trauner, M; Spilka, R; Kiemer, AK; Teufel, A; Maass, T; Moriggl, R; Campbell, JS; Thorgeirsson, SS; Stauffer, J; Karin, M; Llovet, JM; Zatloukal, K; Lackner, C; Haybäck, J
Steatohepatitis-associated Hepatocellular Carcinoma: Evidence of a Keratinopathy.
HEPATOLOGY. 2013; 58(S1):543A-543A.-64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 1-5, 2013; Washington, DC, USA.
[Poster]
Web of Science
Fuchs, CD; Claudel, T; Halilbasic, E; Jha, P; Spindelboeck, W; Stojakovic, T; Trauner, M
FXR controlled CHOP as novel key player in NAFLD progression.
HEPATOLOGY. 2013; 58(S1):542A-542A.-64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 1-5, 2013; Washington, DC, USA.
[Poster]
Web of Science
Fuchs, CD; Claudel, T; Halilbasic, E; Stojakovic, T; Trauner, M
INTRAHEPATIC CHANGES IN BILE ACID COMPOSITION PROTECTS BSEP (ABCB11) KO MICE FROM HEPATIC INFLAMMATION IN METHIONINE CHOLINE DEFICIENT DIET INDUCED NASH.
J HEPATOL. 2013; 58(S1):S32-S32.-48th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 24-28, 2013; Amsterdam, THE NETHERLANDS.
Doi: 10.1016/S0168-8278(13)60072-0
[Oral Communication]
Web of Science
FullText
FullText_MUG
Fuchs, C; Claudel, T; Kumari, P; Stojakovic, T; Halilbasic, E; Spindelboeck, W; Gonzalez, F; Trauner, M
FXR IS A KEY PLAYER IN NAFLD DEVELOPMENT BY CONTROLLING CHOP EXPRESSION.
J HEPATOL. 2012; 56(S2):S490-S490.-47th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN.
Doi: 10.1016/S0168-8278(12)61248-3
[Poster]
Web of Science
FullText
FullText_MUG
Fuchs, CD; Claudel, T; Kumari, P; Stojakovic, T; Haemmerle, G; Halilbasic, E; Gumhold, J; Silbert, D; Koefeler, H; Zechner, R; Trauner, M
ATGL (PNPLA2) KNOCKOUT MICE ARE PROTECTED FROM HEPATIC ER-STRESS VIA OLEIC ACID ACCUMULATION.
J HEPATOL. 2011; 54: S41-S42.-46th Annual Meeting of the European Association for the Study of the Liver (EASL); MAR 30-APR 3, 2011; Berlin, GERMANY.
Doi: 10.1016/S0168-8278(11)60095-0
[Poster]
Web of Science
FullText
FullText_MUG
Fuchs, CD; Claudel, T; Stojakovic, T; Silbert, D; Maurer, B; Trauner, M
BSEP (ABCB11) KO MICE ARE PROTECTED FROM HEPATIC INFLAMMATION IN METHIONINE CHOLINE DEFICIENT DIET INDUCED NASH.
HEPATOLOGY. 2011; 54: 1169A-1169A.-62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 04-08, 2011; San Francisco, USA.
[Poster]
Web of Science